• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜铬粒蛋白2与白细胞免疫球蛋白样受体B4结合,导致免疫抑制。

Secretogranin 2 binds LILRB4 resulting in immunosuppression.

作者信息

Yang Xing, Huang Ryan, Fang Meng, He Yubo, Xie Jingjing, Liu Xiaoye, Zhang Chengcheng, Lou Qi, Deng Mi, Xiong Wei, Lewis Cheryl, Sadek Zade, Gupta Ankit, Chen Lianqi, Zhang Xuewu, Guo Lei, Xu Lin, Zhang Ningyan, An Zhiqiang, Zhang Cheng Cheng

机构信息

Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, USA.

出版信息

Nat Immunol. 2025 Jul 24. doi: 10.1038/s41590-025-02233-4.

DOI:10.1038/s41590-025-02233-4
PMID:40707822
Abstract

Immunosuppressive myeloid cells are important in a variety of physiological and pathological contexts, including tumor development, but how hormones might regulate their activity is unclear. Secretogranins, a family of secretory proteins in endocrine and neuronal cells, are proposed to function as prohormones or hormones, but their specific receptors are unknown. Here we show that secretogranin 2 (SCG2), a granin family member, functionally interacts with leukocyte immunoglobulin-like receptor B4 (LILRB4) on monocytic cells. Tumor-derived SCG2 promotes tumor growth in myeloid-specific LILRB4 transgenic mice in a T cell-dependent manner, whereas SCG2 deficiency in host mice impairs tumor progression and reduces infiltration of immunosuppressive monocytic cells. Blockade of LILRB4 abrogates SCG2-induced signaling, immunosuppression and tumor growth. Mechanistically, this SCG2-LILRB4 interaction triggers SHP recruitment and SHP-independent STAT3 activation. These findings define a function for SCG2 in regulating monocytic immunosuppression and suggest that the SCG2-LILRB4 axis might be a therapeutic target.

摘要

免疫抑制性髓系细胞在包括肿瘤发生在内的多种生理和病理环境中都很重要,但激素如何调节它们的活性尚不清楚。分泌粒蛋白是内分泌和神经元细胞中的一类分泌蛋白,被认为具有激素原或激素的功能,但其具体受体尚不清楚。在这里,我们表明分泌粒蛋白2(SCG2),一种颗粒蛋白家族成员,在单核细胞上与白细胞免疫球蛋白样受体B4(LILRB4)发生功能性相互作用。肿瘤来源的SCG2以T细胞依赖的方式促进髓系特异性LILRB4转基因小鼠的肿瘤生长,而宿主小鼠中SCG2的缺乏会损害肿瘤进展并减少免疫抑制性单核细胞的浸润。阻断LILRB4可消除SCG2诱导的信号传导、免疫抑制和肿瘤生长。从机制上讲,这种SCG2-LILRB4相互作用触发了SHP的募集和不依赖SHP的STAT3激活。这些发现确定了SCG2在调节单核细胞免疫抑制中的功能,并表明SCG2-LILRB4轴可能是一个治疗靶点。

相似文献

1
Secretogranin 2 binds LILRB4 resulting in immunosuppression.嗜铬粒蛋白2与白细胞免疫球蛋白样受体B4结合,导致免疫抑制。
Nat Immunol. 2025 Jul 24. doi: 10.1038/s41590-025-02233-4.
2
The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.免疫检查点LILRB4促进免疫逃逸,并与慢性淋巴细胞白血病的疾病进展和继发性恶性肿瘤相关。
Biomed Pharmacother. 2025 Aug;189:118253. doi: 10.1016/j.biopha.2025.118253. Epub 2025 Jun 13.
3
Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways.通过调节 MAPK 和 NF-κB 通路促进分泌颗粒蛋白 II 在膀胱癌进展中的作用及免疫作用。
Apoptosis. 2024 Feb;29(1-2):121-141. doi: 10.1007/s10495-023-01898-2. Epub 2023 Oct 17.
4
LILRB4 exacerbates myocardial ischemia-reperfusion injury by promoting inflammation and pyroptosis.LILRB4通过促进炎症和细胞焦亡加重心肌缺血再灌注损伤。
Biochim Biophys Acta Mol Basis Dis. 2025 Jun 21;1871(7):167959. doi: 10.1016/j.bbadis.2025.167959.
5
A Switch Protein Adapter for Anti-LILRB4 CAR-T Cells.一种用于抗LILRB4嵌合抗原受体T细胞的开关蛋白适配器。
Eur J Immunol. 2025 Feb;55(2):e202451172. doi: 10.1002/eji.202451172. Epub 2024 Dec 11.
6
LILRB4 specific overexpression in myeloid cells promotes tumor progression and immunosuppression in mouse models.在小鼠模型中,髓系细胞中LILRB4特异性过表达会促进肿瘤进展和免疫抑制。
Biochem Biophys Res Commun. 2025 Apr 1;755:151536. doi: 10.1016/j.bbrc.2025.151536. Epub 2025 Feb 25.
7
Homoharringtonine Promotes FTO Degradation to Suppress LILRB4-Mediated Immune Evasion in Acute Monocytic Leukaemia.高三尖杉酯碱促进FTO降解以抑制急性单核细胞白血病中LILRB4介导的免疫逃逸。
Cell Prolif. 2025 Jul 1:e70090. doi: 10.1111/cpr.70090.
8
Lactylation-Related Gene LILRB4 Predicts the Prognosis and Immunotherapy of Prostate Cancer Based on Machine Learning.基于机器学习的乳酸化相关基因LILRB4预测前列腺癌的预后及免疫治疗效果
J Cell Mol Med. 2025 Jun;29(12):e70669. doi: 10.1111/jcmm.70669.
9
Uncovering the Associations of LILRB4 Genotypes With Parkinson's Disease: From Clinical Traits to Potential Pathologies.揭示LILRB4基因分型与帕金森病的关联:从临床特征到潜在病理机制
CNS Neurosci Ther. 2025 Jul;31(7):e70522. doi: 10.1111/cns.70522.
10
Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.白细胞免疫球蛋白样受体 B4 通过 SHP-2 依赖性抑制 NF-κB 通路来保护心脏免受肥大。
J Mol Med (Berl). 2020 May;98(5):691-705. doi: 10.1007/s00109-020-01896-w. Epub 2020 Apr 12.

本文引用的文献

1
SCG2 mediates blood-brain barrier dysfunction and schizophrenia-like behaviors after traumatic brain injury.SCG2 介导创伤性脑损伤后血脑屏障功能障碍和精神分裂样行为。
FASEB J. 2024 Sep 15;38(17):e70016. doi: 10.1096/fj.202401117R.
2
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.新抗原特异性细胞毒性Tr1 CD4 T细胞抑制癌症免疫疗法。
Nature. 2024 Aug;632(8023):182-191. doi: 10.1038/s41586-024-07752-y. Epub 2024 Jul 24.
3
T cell dysfunction and therapeutic intervention in cancer.T 细胞功能障碍与癌症的治疗干预。
Nat Immunol. 2024 Aug;25(8):1344-1354. doi: 10.1038/s41590-024-01896-9. Epub 2024 Jul 18.
4
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.抗体介导的靶向人小胶质细胞白细胞免疫球蛋白样受体 B4 可减轻小鼠模型中的淀粉样蛋白病理。
Sci Transl Med. 2024 Apr 3;16(741):eadj9052. doi: 10.1126/scitranslmed.adj9052.
5
Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML.Fcγ受体促进抗体诱导的LILRB4内化及单核细胞性急性髓系白血病的免疫调节。
Antib Ther. 2023 Nov 2;7(1):13-27. doi: 10.1093/abt/tbad025. eCollection 2024 Jan.
6
Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors.发现半乳糖凝集素-8 作为 LILRB4 的配体驱动 M-MDSCs,定义了一类用于治疗实体瘤的抗体。
Cell Rep Med. 2024 Jan 16;5(1):101374. doi: 10.1016/j.xcrm.2023.101374.
7
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.LILRB3 支持髓系细胞的免疫抑制活性和肿瘤发展。
Cancer Immunol Res. 2024 Mar 4;12(3):350-362. doi: 10.1158/2326-6066.CIR-23-0496.
8
Human leukocyte immunoglobulin-like receptors in health and disease.人类白细胞免疫球蛋白样受体在健康与疾病中的作用。
Front Immunol. 2023 Nov 13;14:1282874. doi: 10.3389/fimmu.2023.1282874. eCollection 2023.
9
Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways.通过调节 MAPK 和 NF-κB 通路促进分泌颗粒蛋白 II 在膀胱癌进展中的作用及免疫作用。
Apoptosis. 2024 Feb;29(1-2):121-141. doi: 10.1007/s10495-023-01898-2. Epub 2023 Oct 17.
10
Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds.靶向构象依赖性表位的抗tau 抗体选择性结合种子。
J Biol Chem. 2023 Nov;299(11):105252. doi: 10.1016/j.jbc.2023.105252. Epub 2023 Sep 14.